as of 11-06-2026 3:36pm EST
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.
| Founded: | 1863 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 65.4B | IPO Year: | 1999 |
| Target Price: | $107.63 | AVG Volume (30 days): | 3.0M |
| Analyst Decision: | Buy | Number of Analysts: | 18 |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | 6.48 | EPS Growth: | -20.71 |
| 52 Week Low/High: | $67.33 - $103.65 | Next Earning Date: | 11-04-2026 |
| Revenue: | $77,084,000,000 | Revenue Growth: | 8.59% |
| Revenue Growth (this year): | 2.91% | Revenue Growth (next year): | 4.33% |
| P/E Ratio: | 36.36 | Index: | |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
SEC 8-K filings with transcript text
Nov 4, 2026 · 98% conf.
1D
-1.62%
$99.04
Act: -3.05%
5D
-3.35%
$97.30
20D
-0.28%
$100.39
2 ex991earningsreleasetables.htm
EX 99.1 Earnings Release & Tables
Page 1 of 25
Exhibit 99.1
For Immediate Release | Global Communications | MetLife, Inc.
MetLife Announces 3Q 2026 Results
Record company performance, and top-line growth in every business segment.
Earnings
Per Share
Net
Income $3.67
Adjusted
Earnings $2.78
Return
on Equity (ROE)
Adjusted
•Net income increased 187%1 to $2.4 billion, or
$3.67 per share.
•Adjusted earnings increased 12% to $1.8 billion,
driven by higher variable investment income,
broad-based volume growth and favorable
underwriting.
•Adjusted earnings per share up 22% to $2.85,
excluding total notable items — highest-ever
quarter for MetLife.
•Adjusted return on equity of 19.6%, excluding
total notable items.
•Premiums, fees and other revenues (PFOs)
increased 12% to $14.1 billion.
•Adjusted PFOs, excluding pension risk transfers
(PRT), increased 8% to $13.5 billion — with
growth in all six business segments.
•Book value per share (BVPS) down 22% to
$30.73. Adjusted BVPS up 5% to $59.41.
•Returned approximately $1 billion to shareholders
via share repurchases and common stock
dividends.
•Holding company cash and liquid assets totaled
$3.4 billion at quarter end, within our target range.
•On track to deliver against free cash flow ratio and
direct expense ratio2 targets for the year.
Comment from Michel Khalaf, President
and Chief Executive Officer:
We delivered the highest quarterly
adjusted earnings per share in MetLife’s
history in the third quarter, demonstrating
the strength of our New Frontier strategy
and discipline of our execution.
Revenue rose in every business segment,
and solid underwriting, volume growth and
higher investment returns lifted earnings.
We’re turning that into strong free cash
flow, reinvesting for responsible growth
and returning capital to shareholders.
We are firing on all cylinders in year two of
New Frontier, and we remain confident in
our strategy and its ability to drive
repeatable results.
1In this news release, all comparisons of results for the third quarter of 2026 are with the third quarter of 2025, unless
otherwise noted. All year-to-date comparisons are to the first three quarters of 2025. 2Direct expense ratio, excluding
total notable items related to direct expenses and PRT.
Page 2 of 25
Third Quarter 2026 Summary
($ in millions, except per share data)
Three Months Ended
September 30,
2026
2025
Change
Premiums, fees and other revenues
$14,056
$12,526
12%
Net investment income
6,198
6,089
2%
Net investment gains (losses)
(430)
(325)
Net derivative gains (losses)
698
(929)
Total revenues
$20,522
$17,361
Adjusted premiums, fees and other revenues
$13,919
$12,461
12%
Adjusted premiums, fees and other revenues, excluding pension risk
transfers (PRT)
$13,525
$12,471
8%
Market risk benefit remeasurement gains (losses)
$320
$263
22%
Net income (loss)
$2,351
$818
187%
Net income (loss) per share
$3.67
$1.22
201%
Adjusted earnings
$1,780
$1,584
12%
Adjusted earnings per share
$2.78
$2.37
17%
Adjusted earnings, excluding total notable items
$1,826
$1,566
17%
Adjusted earnings, excluding total notable items per share
$2.85
$2.34
22%
Book value per share
$30.73
$39.52
(22)%
Adjusted book value per share
$59.41
$56.57
5%
Expense ratio
21.3%
21.7%
Direct expense ratio, excluding total notable items related to direct
expenses and PRT
11.9%
11.6%
Adjusted expense ratio, excluding total notable items related to
adjusted other expenses and PRT
20.2%
19.8%
ROE
42.7%
13.1%
Adjusted ROE
19.2%
16.9%
Adjusted ROE, excluding total notable items
19.6%
16.7%
Information regarding the non-GAAP and other financial measures included in this news release
and reconciliation of the non-GAAP financial measures to GAAP measures are in “Non-GAAP
and Other Financial Disclosures” below and in the tables that accompany this news release.
Supplemental slides for the third quarter of 2026, titled “3Q26 Earnings Call Presentation,” are
available on the MetLife Investor Relations website at https://investor.metlife.com and in the
Form 8-K furnished by MetLife to the U.S. Securities and Exchange Commission in connection
with this earnings release. Supplemental information about MetLife's diversified global
investment portfolio is contained in the "3Q26 - General Account Assets Under Management
Fact Sheet," available on the above-mentioned website.
Page 3 of 25
Total Company Discussion
Premiums, fees and other revenues were $14.1 billion, up 12 percent compared with the
prior-year quarter. Adjusted premiums, fees and other revenues, excluding PRT, were
$13.5 billion, up 8 percent.
Net investment income was $6.2 billion, up 2 percent, due to higher variable investment
income (VII) and asset growth, partially offse
Aug 5, 2026 · 100% conf.
1D
-1.63%
$94.69
Act: +3.83%
5D
-3.38%
$93.01
Act: +0.42%
20D
-0.28%
$95.99
Transcript text not available. View on SEC.gov →
May 6, 2026
See how MET stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "MET MetLife Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.